RNA Earnings Date: Nov 12, 2026 (Estimated) — Atrium Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is RNA's next earnings date?
Atrium Therapeutics, Inc. (RNA) is expected to report earnings on Thursday, November 12, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.81 on revenue of $15.0M.
How did RNA do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Atrium Therapeutics, Inc. posted EPS of -$1.18 versus the -$1.42 estimate, a beat of 53.3%. Revenue was $3.0M against a $666,667 estimate. The stock's 1-day post-earnings move was +4.1%.
How much does RNA stock move after earnings?
RNA beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 3.0% (up or down) in the day after earnings.
About Atrium Therapeutics, Inc.
Atrium Therapeutics, Inc. is a biopharmaceutical company dedicated to revolutionizing the treatment of cardiomyopathies by delivering innovative ribonucleic acid (RNA) therapeutics directly to the heart. Their development-stage portfolio currently includes ATR 1072, a siRNA-based therapy targeting the PRKAG2 gene for the treatment of PRKAG2 syndrome, and ATR 1086, another siRNA therapy aimed at the PLN gene to address PLN cardiomyopathy. The company is also actively developing a wider range of pipeline candidates designed to combat various genetic and cardiac diseases. Founded in 2025, Atrium Therapeutics is based in San Diego, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -1.42 | -1.18 | -53.25% | $3.0M | ✅ Beat | +4.14% | +9.33% | -17.19% |
| 2026-05-14 | Q1 2026 | -1.10 | -0.97 | +11.82% | $19.6M | ✅ Beat | -0.30% | -1.73% | -3.92% |
| 2025-11-10 | Q3 2025 | -1.08 | -1.27 | -17.59% | $12.5M | ❌ Miss | +1.23% | +1.20% | +2.16% |
| 2025-02-27 | Q4 2024 | -0.78 | -0.80 | -2.56% | $3.0M | ❌ Miss | +5.36% | +4.37% | +8.67% |
| 2024-11-07 | Q3 2024 | -0.73 | -0.65 | +10.96% | $2.3M | ✅ Beat | -1.66% | +5.18% | -22.44% |
| 2024-08-09 | Q2 2024 | -0.79 | -0.65 | +17.72% | $2.0M | ✅ Beat | -5.26% | -4.20% | -13.12% |
| 2023-11-08 | Q3 2023 | -0.77 | -0.71 | +7.79% | $2.8M | ✅ Beat | +1.11% | +14.94% | +39.11% |
| 2023-08-08 | Q2 2023 | -0.80 | -0.66 | +17.50% | $2.3M | ✅ Beat | +4.70% | -2.80% | -22.28% |
Showing last 8 quarters.